Physician profile
Manuel Romo
NPI 1902458045
$960.53
in general payments reported to CMS, 2019-2025
18 companies · $175 in 2025
The $175 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $690 · 2022: $80.52 · 2024: $14.69 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $190.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $223.73 | 2021 | |
| Boston Scientific Corporation | $175.36 | 2025 | General - Stents, Avvigo Guidance System, Rotablator Rotational Atherectomy System Console Kit |
| Abbvie INC. | $82.22 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.62 | 2021 | |
| Lilly USA, LLC | $56.52 | 2021 | |
| Amgen INC. | $48.95 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $46.77 | 2021-2022 | |
| Amarin Pharma, INC. | $34.16 | 2021 | |
| Novo Nordisk INC | $31.64 | 2021 | |
| Janssen Pharmaceuticals, INC | $28.11 | 2021-2022 | |
| Abbott Laboratories | $24.88 | 2021 | |
| Nestle Healthcare Nutrition INC. | $24.16 | 2021-2022 | |
| Pfizer INC. | $20.29 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.47 | 2021 | |
| Phadia US INC. | $19.17 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $19.14 | 2021 | |
| Exact Sciences Corporation | $14.69 | 2024 | Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $13.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuel Romo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.